Clin2
NCT07040592Possibly a fitRecruiting

Semaglutide for HIV and alcohol use

Alcohol Use Disorder (AUD)HIV

Treatments studied

Part of Mental health clinical trials.

This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
30 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You are diagnosed with HIV and get your care at the Atlanta VA Healthcare System.
  • You are 18 years or older.
  • You have mild, moderate, or severe alcohol use disorder.
  • You have evidence of recent heavy drinking (blood test showing PEth >20 ng/mL).
  • You are currently taking 5 or more medications.
  • You are not currently in treatment or taking medication specifically for alcohol use disorder.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07772960Not yet recruiting· Phase 1
Semaglutide for alcohol use and weight loss

This study tests whether semaglutide, a medication that helps with weight loss, can also reduce alcohol cravings and drinking in people with alcohol use disorder. It may help you drink less and lose weight.

New Haven, Connecticut
NCT07221214Recruiting· Phase 2
Testing a diabetes drug for drinking and heart health in HIV

This trial tests if a once-weekly diabetes medication (semaglutide) can help people with HIV reduce heavy drinking and improve heart health. It's for people who drink alcohol and have a higher body weight.

Nashville, Tennessee
NCT06691243Recruiting· Phase 2
Testing semaglutide for cocaine use in adults

This study tests if the diabetes drug semaglutide (also used for weight loss) can help reduce cocaine use in adults, including those living with HIV. It's free and lasts about 8 weeks.

Washington D.C., District of Columbia
NCT06546384Not yet recruiting
Semaglutide for alcohol use and liver health in obesity and fatty liver

This study tests if semaglutide (a GLP-1 RA medicine) can reduce alcohol consumption and improve liver fat and metabolism in people with obesity and fatty liver disease who drink above certain levels.

Bern
NCT07223983Recruiting· Phase 1
Semaglutide for alcohol use disorder after weight loss surgery

This trial tests if a once-weekly diabetes medication (semaglutide) can help people with alcohol use disorder who have had gastric bypass or sleeve gastrectomy in the past 7 years. It may reduce alcohol cravings or drinking.

New Haven, Connecticut
NCT07218354Recruiting· Phase 3
Medication for reducing alcohol use in veterans

This study tests whether a medication (semaglutide) can help veterans reduce or stop drinking alcohol. It is for veterans who drink heavily and have alcohol use disorder, and who are interested in cutting down.

Long Beach, California

Hear when a new HIV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.